BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12708906)

  • 1. Molecular monitoring of cerebrospinal fluid can predict clinical relapse in acute lymphoblastic leukemia with eosinophilia.
    Nuñez CA; Zipf TF; Roberts WM; Medeiros LJ; Hayes K; Bueso-Ramos CE
    Arch Pathol Lab Med; 2003 May; 127(5):601-5. PubMed ID: 12708906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential monitoring of minimal residual disease in acute lymphoblastic leukemia: 7-year experience in a pediatric hematology/oncology unit.
    Katsibardi K; Moschovi MA; Braoudaki M; Papadhimitriou SI; Papathanasiou C; Tzortzatou-Stathopoulou F
    Leuk Lymphoma; 2010 May; 51(5):846-52. PubMed ID: 20350276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Ig and T-cell receptor genes in 40 childhood acute lymphoblastic leukemias at diagnosis and subsequent relapse: implications for the detection of minimal residual disease by polymerase chain reaction analysis.
    Beishuizen A; Verhoeven MA; van Wering ER; Hählen K; Hooijkaas H; van Dongen JJ
    Blood; 1994 Apr; 83(8):2238-47. PubMed ID: 8161789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Considerations for monitoring minimal residual disease using immunoglobulin clonality in patients with precursor B-cell lymphoblastic leukemia.
    Jo I; Chung NG; Lee S; Kwon A; Kim J; Choi H; Jang W; Kim S; Lee JW; Yoon JH; Cho B; Han K; Kim Y; Kim M
    Clin Chim Acta; 2019 Jan; 488():81-89. PubMed ID: 30389459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group.
    Cavé H; van der Werff ten Bosch J; Suciu S; Guidal C; Waterkeyn C; Otten J; Bakkus M; Thielemans K; Grandchamp B; Vilmer E
    N Engl J Med; 1998 Aug; 339(9):591-8. PubMed ID: 9718378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cerebrospinal fluid eosinophilia preceding central nervous system leukemia].
    Law KL; Nang-Kin ; Lin HY; Chi CS
    Zhonghua Yi Xue Za Zhi (Taipei); 1989 Apr; 43(4):273-6. PubMed ID: 2804781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility of next generation sequencing to detect IGH/IL3 rearrangements [t(5;14)(q31.1;q32.1)] in B-lymphoblastic leukemia/lymphoma.
    Guenzel AJ; Smadbeck JB; Golden CL; Williamson CM; Benevides Demasi JC; Vasmatzis G; Pearce KE; Olteanu H; Xu X; Hoppman NL; Greipp PT; Baughn LB; Ketterling RP; Peterson JF
    Ann Diagn Pathol; 2021 Aug; 53():151761. PubMed ID: 33991782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A practical strategy of monitoring minimal residue disease and intervention for central nervous system relapse of childhood acute lymphoblastic leukemia: a single Chinese center's experience.
    Liang Y; Ca Q; Zhai ZM; Wang NL
    J Pediatr Hematol Oncol; 2013 Jul; 35(5):388-93. PubMed ID: 23787730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A set of genes that regulate cell proliferation predicts treatment outcome in childhood acute lymphoblastic leukemia.
    Flotho C; Coustan-Smith E; Pei D; Cheng C; Song G; Pui CH; Downing JR; Campana D
    Blood; 2007 Aug; 110(4):1271-7. PubMed ID: 17456722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimal residual disease in cerebrospinal fluid at diagnosis: a more intensive treatment protocol was able to eliminate the adverse prognosis in children with acute lymphoblastic leukemia.
    Biojone E; Queiróz Rde P; Valera ET; Odashima NS; Takayanagui OM; Viana MB; Tone LG; Scrideli CA
    Leuk Lymphoma; 2012 Jan; 53(1):89-95. PubMed ID: 21774746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonality profile in relapsed precursor-B-ALL children by GeneScan and sequencing analyses. Consequences on minimal residual disease monitoring.
    Germano G; del Giudice L; Palatron S; Giarin E; Cazzaniga G; Biondi A; Basso G
    Leukemia; 2003 Aug; 17(8):1573-82. PubMed ID: 12886245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Power of the MAC (morphology-antibody-chromosomes) method in distinguishing reactive and clonal cells: report of a patient with acute lymphatic leukemia, eosinophilia, and t(5;14).
    Knuutila S; Alitalo R; Ruutu T
    Genes Chromosomes Cancer; 1993 Dec; 8(4):219-23. PubMed ID: 7512364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of detection of monoclonality in remission marrow in acute lymphoblastic leukemia in childhood. Australian and New Zealand Children's Cancer Study Group.
    Brisco MJ; Condon J; Hughes E; Neoh SH; Nicholson I; Sykes PJ; Tauro G; Ekert H; Waters K; Toogood I
    Leukemia; 1993 Oct; 7(10):1514-20. PubMed ID: 8412313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent central nervous system acute lymphoblastic leukemia associated with cerebrospinal fluid eosinophilia and basophilia: a proposed cytokine-mediated mechanism.
    Fasipe F; Bestak M; Green NS
    Pediatr Hematol Oncol; 2003; 20(1):31-7. PubMed ID: 12687751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy.
    Tzortzatou-Stathopoulou F; Papadopoulou AL; Moschovi M; Botsonis A; Tsangaris GT
    J Pediatr Hematol Oncol; 2001 Dec; 23(9):591-7. PubMed ID: 11902303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late relapse of childhood acute lymphoblastic leukemia and pcr-monitoring of minimal residual disease: how much time can elapse between "molecular" and clinical relapse?
    Aricò M; Germano G; del Giudice L; Ziino O; Locatelli F; Basso G
    Haematologica; 2002 Apr; 87(4):ELT19. PubMed ID: 11940504
    [No Abstract]   [Full Text] [Related]  

  • 17. Bridging the gap between the north and south of the world: the case of treatment response in childhood acute lymphoblastic leukemia.
    Stanulla M; Schrauder A
    Haematologica; 2009 Jun; 94(6):748-52. PubMed ID: 19483150
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunoglobulin gene rearrangement in detection of minimal residual disease in acute lymphoblastic leukaemia.
    Nayyar A; Ahmed S
    J Ayub Med Coll Abbottabad; 2013; 25(1-2):159-61. PubMed ID: 25098084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Childhood acute lymphoblastic leukemia: are routine end-of-therapy bone marrow and cerebrospinal fluid examinations necessary?
    Hutt PJ; Sabio H; Gilchrist GS; O'Brien C
    Mayo Clin Proc; 1996 Sep; 71(9):854-6. PubMed ID: 8790260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular detection of acute lymphoblastic leukaemia in boys with testicular relapse.
    Lal A; Kwan E; al Mahr M; Zhou L; Ferrara D; Tobias V; O'Gorman Hughes D; Haber M; Norris MD; Marshall GM
    Mol Pathol; 1998 Oct; 51(5):277-81. PubMed ID: 10193523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.